Evidence map›Paper›PMID 41035404›Full record

ArticleHaematologica2026

Intravenous immunoglobulins in the management of acute chest syndrome in two Jehovah's Witnesses with sickle cell disease.

Francesca Begali, Jacopo Ceolan, Silvia Vitale, Simone Villaboni, Matteo Merlo, Rachele Zamperini, Roberto Bertazzo, Soraia Ribeiro Luz, Filippo Mazzi, Lucia De Franceschi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Francesca BegaliAzienda Ospedaliera Universitaria Integrate, Verona, Italy; Department of Engineering for Innovative Medicine, University of Verona.
Jacopo CeolanAzienda Ospedaliera Universitaria Integrate, Verona, Italy; Department of Engineering for Innovative Medicine, University of Verona.
Silvia VitaleAzienda Ospedaliera Universitaria Integrate, Verona, Italy; Department of Engineering for Innovative Medicine, University of Verona.
Simone VillaboniAzienda Ospedaliera Universitaria Integrate, Verona, Italy; Department of Engineering for Innovative Medicine, University of Verona.
Matteo MerloAzienda Ospedaliera Universitaria Integrate, Verona, Italy; Department of Engineering for Innovative Medicine, University of Verona.
Rachele ZamperiniAzienda Ospedaliera Universitaria Integrate, Verona, Italy; Department of Engineering for Innovative Medicine, University of Verona.
Roberto BertazzoAzienda Ospedaliera Universitaria Integrate, Verona, Italy; Department of Engineering for Innovative Medicine, University of Verona.
Soraia Ribeiro LuzDepartment of Engineering for Innovative Medicine, University of Verona.
Filippo MazziAzienda Ospedaliera Universitaria Integrate, Verona.
Lucia De FranceschiAzienda Ospedaliera Universitaria Integrate, Verona, Italy; Department of Engineering for Innovative Medicine, University of Verona. lucia.defranceschi@univr.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41035404
PMCPMC12951150

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.